Document Detail

Anti-oxidative and anti-aging activities of 2-O-α-glucopyranosyl-l-ascorbic acid on human dermal fibroblasts.
MedLine Citation:
PMID:  22119379     Owner:  NLM     Status:  Publisher    
A stable ascorbic acid derivative, 2-O-α-glucopyranosyl-l-ascorbic acid (AA-2G), was evaluated and compared with ascorbic acid for its protective effect against cellular damage and senescence induced by hydrogen peroxide (H(2)O(2)). Pretreatment with AA-2G for 72h promoted the proliferation of normal human dermal fibroblasts (NHDF) and protected against cell damage induced by H(2)O(2). In contrast, ascorbic acid increased the proliferation and protected against cell damage, only when culture medium containing ascorbic acid was replaced every 24h during the pretreatment period. These results suggest that the effect of AA-2G is longer-lasting compared to that of ascorbic acid. Senescence associated-β-galactosidase (SA-β-gal) activity, a classical biomarker of cellular senescence, was increased in H(2)O(2)-exposed NHDF cells, but pretreatment or posttreatment with ascorbic acid or AA-2G significantly inhibited the increase in SA-β-gal levels. AA-2G was more potent than ascorbic acid in down-regulating SA-β-gal activity. Expression of SIRT1, which has attracted attention as an anti-aging factor in recent years, was significantly decreased in H(2)O(2)-exposed NHDF cells compared to untreated cells. However, pretreatment NHDF cells with AA-2G before H(2)O(2) exposure significantly inhibited this decrease in SIRT1 expression, whereas ascorbic acid had no effect. After H(2)O(2) exposure, the expression levels of p53 and p21 were increased in NHDF cells and pretreatment with AA-2G inhibited this increase. Together, these results suggest that AA-2G protects dermal fibroblasts from oxidative stress and cellular senescence. These characteristics indicate that AA-2G could become a promising material for its anti-aging properties.
Mutsuko Taniguchi; Norie Arai; Keizo Kohno; Shimpei Ushio; Shigeharu Fukuda
Related Documents :
9010639 - In vitro and in vivo disposition of 2,2-dimethyl-n-(2,4,6-trimethoxyphenyl)dodecanamide...
8482369 - Starvation effect on rat kidney peroxisomal and microsomal fatty acid oxidation. a comp...
10577999 - Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disor...
7244329 - Antiketogenic effect of gluconeogenic substrates. ii. effect of pyruvate.
18485779 - Intrauterine cardiomyopathy and cardiac mitochondrial proliferation in mitochondrial tr...
2967979 - Biochemical mechanisms of oxfenicine cardiotoxicity.
1691969 - The p300 event-related potentials in dementia of the alzheimer type. correlations betwe...
15093519 - Accumulation of aluminum and iron by bryophytes in streams affected by acid-mine drainage.
8639489 - Mechanism of lipoxygenase inactivation by the linoleic acid analogue octadeca-9,12-diyn...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-21
Journal Detail:
Title:  European journal of pharmacology     Volume:  -     ISSN:  1879-0712     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Contractile activity of the bladder urothelium/lamina propria and its regulation by nitric oxide.
Next Document:  PPADS, a P2X receptor antagonist, as a novel inhibitor of the reverse mode of the Na(+)/Ca(2+) excha...